HA
HAVN Life Sciences Inc.
HAVLF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $3.56K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Debt/Assets N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
19 /100
Unstable Profitable years 0
Beta -0.30x
EPS volatility 26,851.12%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre HAVLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tim Moore
Employees
6
Headquarters
Port Moody